At a Glance
Regime: Weak · Open: Gap down · Risk on new positions: High · Custom T2108: 36.7, rising
Focus: Existing Positions
Tonight After Hours: NEM, RNG, VRSN · Tomorrow Before Open: —
Holding: CLF, HAS
Situational Awareness
Market Condition: Gap Down, Weak, Correction
Commentary: Doing nothing yesterday was a good idea. Same again today for me. The NQ looks like a text book weak structure short. The reaction to META, TSLA, IBM, TXN etc. last night was initially positive but flipped negative as the evening went on.

There are likely macro war narratives influencing also. Regardless of the reason there is zero reason to be trying to long tech catalysts here this morning. Relax and save the mental and physical capital.
We had the weak TQQQ/SOXL bounce. A better opportunity for that bounce is likely to come in the near future. Let’s see how we close today.
Today In Focus
N/A
Also in Play
N/A
Trade Updates
Open:
CLF - Earnings Catalyst - 19th October 2026 - 100% Remaining
HAS - Earnings Catalyst - 20th October 2026 - 100% Remaining
Trims: —
Closed since yesterday: —
Macro Events (Eastern Time)
N/A
IPOs Today
Thu 22 Oct: DAVI - Davion Healthcare Plc Ordinary Shares - NASDAQ - Davion Healthcare Plc is an Irish Public Limited company focused exclusively on the development and commercialization of non-invasive home tests for the early detection of health anomalies, including cancers.
Thu 22 Oct: IDXG - Interpace Biosciences, Inc. - NASDAQ - Interpace Biosciences, Inc.
Thu 22 Oct: NANO - Forge Nano Holdings Inc. Common Stock - NASDAQ
Biotech Calendar
XBI +4.4% on the week and -3.2% on the month, under its 50-day. The sector tailwind is gone for now. Reactions have to prove themselves.
Flagged Charts: N/A
Note: Never front-run biotech catalysts. Wait for the catalyst to hit, then assess if the reaction is tradable. Dates are estimates and can shift.
Full H2 Biotech Watchlist: TradingView
Have a Great Week!
Sean Sharpe


